{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-380171","form_type":"8-K","ticker":"PBLS","cik":"0001657677","company_name":"Parabilis Medicines, Inc.","filed_at":"2026-09-02T20:05:15+00:00","discovered_at":"2026-09-02T20:06:00.415380+00:00","generated_at":"2026-09-02T20:06:32.257977+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Parabilis Medicines CMO Fawzi Benzaghou to depart effective Sept 30, 2026","bullets":["Chief Medical Officer Fawzi Benzaghou, M.D. and company mutually agreed to his transition, effective September 30, 2026.","Dr. Benzaghou will receive severance benefits pursuant to his employment agreement.","No replacement CMO has been named in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-380171","json":"https://secwatch.observer/filing/0001193125-26-380171.json","markdown":"https://secwatch.observer/filing/0001193125-26-380171.md","text":"https://secwatch.observer/filing/0001193125-26-380171.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1657677/000119312526380171/0001193125-26-380171-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1657677/000119312526380171/ck0001657677-20260828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T20:06:32.257977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}